CLINICAL_TRIALS
trial_result
· 2016-05-26
Clinical Trial Update: Open-Label Lesinurad Monotherapy Extension Study in Gout [Phase 3]
Summary
An open-label extension study of lesinurad monotherapy for gout has completed Phase 3 research, with results posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ardea Biosciences, Inc. | Conditions: Gout | Phase 3 | Status: COMPLETED | Results posted: 2016-05-26